Browse Category

Stock Market News 9 December 2025

Astera Labs (ALAB) Stock Jumps on AI Optimism: Latest News, Analyst Price Targets and Forecasts for December 9, 2025

Astera Labs (ALAB) Stock Jumps on AI Optimism: Latest News, Analyst Price Targets and Forecasts for December 9, 2025

Astera Labs, Inc. (NASDAQ: ALAB) is back in the spotlight on Tuesday, December 9, 2025, as the AI‑infrastructure specialist rallies and fresh analyst commentary and institutional filings reshape the narrative around one of the market’s most closely watched semiconductor IPOs. As of late-morning U.S. trading, Astera Labs shares were changing hands around $175.74, up roughly 9% on the day, after closing near $161 in the prior session. That move comes after several weeks of heavy volatility following its latest earnings report and the AWS re:Invent conference. Below is a comprehensive look at today’s news, recent corporate developments, Wall Street forecasts,
Toll Brothers Stock Slides After Q4 2025 Earnings Miss and Cautious 2026 Outlook: What It Means for TOL Investors

Toll Brothers Stock Slides After Q4 2025 Earnings Miss and Cautious 2026 Outlook: What It Means for TOL Investors

December 9, 2025 — New York Stock Exchange: TOL Toll Brothers, Inc. (NYSE: TOL), the largest U.S. builder of luxury homes, is under pressure today after reporting fiscal Q4 2025 results that combined a solid revenue performance with softer margins, weaker cash flow, and a cautious outlook for 2026. Shares are trading around $136 in early Tuesday action, down roughly 2% from Monday’s close of $138.94, as investors digest an earnings-per-share (EPS) miss and guidance that points to lower deliveries next fiscal year. Even after the pullback, the stock remains up around 8–10% year-to-date and not far from its 52‑week
NextEra Energy (NEE) Stock on December 9, 2025: Google Cloud AI Grid Deal, Price Action and Analyst Forecasts

NextEra Energy (NEE) Stock on December 9, 2025: Google Cloud AI Grid Deal, Price Action and Analyst Forecasts

Dateline: December 9, 2025 NextEra Energy, Inc. (NYSE: NEE) is back in the spotlight this week as investors digest a flurry of news: a landmark AI-focused partnership with Google Cloud, 2.5 GW of new clean‑energy contracts with Meta, an ambitious gas‑fueled data‑center strategy with Exxon, and updated long‑term earnings guidance out of its New York investor day. All of that is hitting the tape while the stock consolidates after a strong 2025 rally and a sharp pullback in the last session. NextEra Energy stock today: price, performance and dividend By late morning U.S. trading on December 9, 2025, NextEra Energy
Sea Limited (SE) Stock: Q3 2025 Earnings, $1 Billion Buyback and 2026 Price Targets Explained

Sea Limited (SE) Stock: Q3 2025 Earnings, $1 Billion Buyback and 2026 Price Targets Explained

Sea Limited’s stock has had a whiplash year. After soaring earlier in 2025, the shares have pulled back sharply following third‑quarter earnings, even as the company delivered some of its strongest growth metrics in years and announced a $1 billion share repurchase program. As of intraday trading on December 9, 2025, Sea Limited (NYSE: SE) is changing hands around $128 per share, down about 4% on the day and roughly a third below its 52‑week high near $199.dcfmodeling.com The question now dominating investor conversations: is this a buying opportunity, or a warning sign that expectations have run too far ahead
Warner Bros. Discovery (WBD) Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery (WBD) Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery, Inc. (NASDAQ: WBD) is trading like a Hollywood cliffhanger on Tuesday, December 9, 2025. Shares are changing hands around the mid‑$27 range after jumping more than 4% intraday, extending a rally that has seen the stock climb roughly 140–150% over the past year. Smartkarma The catalyst: Paramount Skydance’s surprise all‑cash hostile bid of $30 per share, valuing Warner Bros. Discovery at about $108.4 billion including debt and directly challenging Netflix’s already‑signed $72 billion cash‑and‑stock agreement for WBD’s studios and streaming operations. Reuters+2PR Newswire+2 Below is a detailed look at the latest news, the takeover mechanics, analyst forecasts,
Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

As Cemtrex, Inc. (NASDAQ: CETX) heads into trading on Tuesday, December 9, 2025, the tiny tech stock is coming off one of the wildest sessions on the Nasdaq. On Monday, December 8, Cemtrex shares closed at $7.05, up 129.64% from Friday’s close of $3.07, after trading in an extraordinary intraday range of $4.84 to $9.70. StockAnalysis+2StockInvest+2Pre‑market quotes early Tuesday show the stock giving back part of that move, trading around the low‑$6 area (roughly –14% versus Monday’s close), but still far above last week’s levels. StockAnalysis+1 Despite the eye‑popping rally, Cemtrex remains a micro‑cap: its market value sits around $5
Sezzle Inc (SEZL) Stock Outlook: S&P SmallCap 600 Inclusion, Earnings Surge and Price Forecast

Sezzle Inc (SEZL) Stock Outlook: S&P SmallCap 600 Inclusion, Earnings Surge and Price Forecast

Data and news current as of 9 December 2025. This article is for informational purposes only and is not financial advice. Sezzle stock in December 2025: from hyper-growth to “serious contender” Sezzle Inc (NASDAQ: SEZL), the buy-now-pay-later (BNPL) fintech once written off as a niche player, has turned into one of 2025’s wildest rides on the Nasdaq. After a run that saw the stock up around 1,000% over the past year at one point, followed by drawdowns of 40%–70% from its peak, Sezzle has settled—for now—into the role of highly volatile, profitable growth stock with real earnings and real scrutiny.
‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

Published: 9 December 2025 A heavily mutated flu strain — A/H3N2 subclade K, often dubbed the “K-strain” or “superflu” — is now dominating the 2025–26 flu season and driving record levels of illness in parts of the UK and beyond. On Tuesday, new analysis showed that this K-strain now accounts for around 90% of flu samples in the UK and Japanand has been detected on every continent.The Independent+1 At the same time, NHS leaders in London warn of the “biggest flu wave ever” in the capital, with hospital flu admissions tripling compared with this time last year and “no peak yet in sight”.The Standard Yet there is some good news: early
9 December 2025
UK Stock Market Movers Today (9 December 2025): Most‑Active FTSE 100 Stocks and What’s Driving Them

UK Stock Market Movers Today (9 December 2025): Most‑Active FTSE 100 Stocks and What’s Driving Them

The UK stock market spent Tuesday 9 December 2025 in a holding pattern, with the FTSE 100 drifting around 9,650 points and ending effectively flat, as traders waited for a key US Federal Reserve decision and next week’s Bank of England meeting. Reuters Beneath the calm index level, trading activity was intense in a familiar set of big‑name stocks: banks, energy giants, consumer staples, telecoms and tobacco. According to the London Stock Exchange and live dealing platforms, volume was concentrated in Lloyds, Legal & General, Glencore, Vodafone, Barclays, Tesco, BP, BT, Rolls‑Royce, Magnum Ice Cream and British American Tobacco, among others. Hargreaves Lansdown This article
UK Stock Market Top Losers Today (9 December 2025): BAT Leads FTSE 100 Fallers as Unilever Hangover Lingers

UK Stock Market Top Losers Today (9 December 2025): BAT Leads FTSE 100 Fallers as Unilever Hangover Lingers

The UK stock market spent Tuesday, 9 December 2025, in a cautious mood, with a handful of big names doing most of the damage. The FTSE 100 slipped around 0.1% to roughly 9,640, its lowest close in about two weeks, as investors positioned for a crucial Federal Reserve decision and another Bank of England rate call. TradingView+1 While the index is still hovering near record highs for 2025, British American Tobacco, Chemring and Ashtead were among the standout losers today, and Monday’s sharp falls in Unilever, Barratt Redrow, JD Sports Fashion, Persimmon and Entain are still shaping sentiment. TechStock²+1 Market snapshot: Cautious FTSE 100, weak consumers Two
UK Stock Market Today: Unilever, WPP, Babcock, Trustpilot and Ocado Lead Top Gainers on 9 December 2025

UK Stock Market Today: Unilever, WPP, Babcock, Trustpilot and Ocado Lead Top Gainers on 9 December 2025

The UK stock market nudged higher on Tuesday 9 December 2025, but beneath the calm headline numbers there were some dramatic individual moves – led by a double‑digit jump in Unilever and sharp gains in WPP, defence contractor Babcock, and mid‑cap names such as Trustpilot, Ocado, Helios Towers, Man Group and Moonpig. The FTSE 100 closed fractionally up at 9,653.19 (+0.08%), while the FTSE 250 added 0.17% to 21,957.79, both indices finishing in positive territory after a cautious session. European markets more broadly were also slightly higher, with investors focused on the US Federal Reserve’s two‑day policy meeting that begins later today.
Structure Therapeutics (NASDAQ: GPCR) Stock Explodes on Obesity Pill Data and $500M Offering: Latest News and Forecasts as of December 9, 2025

Structure Therapeutics (NASDAQ: GPCR) Stock Explodes on Obesity Pill Data and $500M Offering: Latest News and Forecasts as of December 9, 2025

Snapshot: Where Structure Therapeutics Stock Stands Today Structure Therapeutics Inc. (NASDAQ: GPCR) has suddenly moved from niche obesity biotech to front‑page market story. As of December 9, 2025, GPCR is trading around $69.98, up roughly 102% in a single session compared with its previous close near $34.56. The stock’s intraday range on December 8 ran from $44.74 to $94.90, marking a new 52‑week high, and lifting its market capitalization to about $4.25 billion.StockAnalysis+1 This explosive move followed positive Phase 2b trial data for the company’s oral GLP‑1 obesity drug aleniglipron and the announcement of a proposed $500 million public offering

Stock Market Today

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

7 February 2026
Walmart shares rose 3.3% Friday to $131.18, up 10% since Jan. 30, as the Dow closed above 50,000 for the first time. The retailer’s market value crossed $1 trillion this week. Investors await January inflation data on Feb. 13 and Walmart’s quarterly results on Feb. 19 for signs of continued momentum.
Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

7 February 2026
Caterpillar shares surged 7.1% to $726.20 Friday, driving the Dow above 50,000 for the first time. The move erased recent losses and followed insider selling by Group President Bob De Lange earlier in the week. Deere and CNH Industrial also gained as investors rotated into industrial stocks. Markets await next week’s U.S. jobs and inflation data.
Go toTop